Category: Articles

  • 2019 Endovascular Today PERT Supplement

    Greetings PERT Consortium members and friends.   Please check out the PERT Supplement, published by our partners at Endovascular Today this past month.  This is a highly informative update and “state of the art” with respect to Pulmonary Embolism: epidemiology; diagnosis; risk stratification; treatment options and outcomes; and long-term followup and consequences. The PERT Consortium […]

  • A PERT’s initial 20 month experience treating 87 patients with submassive and massive pulmonary embolism.

    Pulmonary Embolism Response Teams (PERTs) have emerged to provide rapid multidisciplinary assessment and treatment of PE patients. However, descriptive institutional experience and preliminary outcomes data from such teams are sparse. PERT activations were identified through a retrospective review. Only confirmed submassive or massive PEs were included in the data analysis. In addition to baseline variables, […]

  • Systemic Thrombolysis for PE:
    Who and How

    Anticoagulation has been shown to improve mortality in acute pulmonary embolism (PE). Initiation of anticoagulation should be considered when PE is strongly suspected and the bleeding risk is perceived to be low, even if acute PE has not yet been proven. Low-risk patients with acute PE are simply continued on anticoagulation. Severely ill patients with high-risk (massive) PE […]

  • VTE and Persistent PH in Cancer Patients: A Cross-Sectional Study

    In a prospective study of patients with a history of cancer or other active malignant disease, researchers suggested a link between the formation of blood clots in leg, known as venous thromboembolism (VTE) and pulmonary hypertension (PH) which is a type of high blood pressure affecting the heart or lungs. It is important to note […]